Becker Hewes's most recent trade in Blueprint Medicines Corp was a trade of 4,863 Common Stock done at an average price of $88.8 . Disclosure was reported to the exchange on March 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Blueprint Medicines Corp | Becker Hewes | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 88.80 per share. | 05 Mar 2025 | 4,863 | 35,651 (0%) | 0% | 88.8 | 431,834 | Common Stock |
| Blueprint Medicines Corp | Becker Hewes | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 87.42 per share. | 05 Mar 2025 | 2,691 | 32,960 (0%) | 0% | 87.4 | 235,247 | Common Stock |
| Blueprint Medicines Corp | Becker Hewes | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 87.98 per share. | 05 Mar 2025 | 2,541 | 30,419 (0%) | 0% | 88.0 | 223,557 | Common Stock |
| Blueprint Medicines Corp | Becker Hewes | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 22,000 | 22,000 | - | - | Stock Options (Right to Buy) | |
| Blueprint Medicines Corp | Becker Hewes | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 11,000 | 40,514 (0%) | 0% | 0 | Common Stock | |
| Blueprint Medicines Corp | Becker Hewes | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 104.91 per share. | 04 Jun 2024 | 2,424 | 29,514 (0%) | 0% | 104.9 | 254,302 | Common Stock |
| Blueprint Medicines Corp | Becker Hewes | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 105.81 per share. | 31 May 2024 | 20,904 | 43,202 (0%) | 0% | 105.8 | 2,211,852 | Common Stock |
| Blueprint Medicines Corp | Becker Hewes | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 66.24 per share. | 31 May 2024 | 10,573 | 56,854 (0%) | 0% | 66.2 | 700,356 | Common Stock |
| Blueprint Medicines Corp | Becker Hewes | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 10,573 | 13,490 | - | - | Stock Options (Right to Buy) | |
| Blueprint Medicines Corp | Becker Hewes | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 8,385 | 9,115 | - | - | Stock Options (Right to Buy) | |
| Blueprint Medicines Corp | Becker Hewes | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 61.31 per share. | 31 May 2024 | 8,385 | 65,239 (0%) | 0% | 61.3 | 514,084 | Common Stock |
| Blueprint Medicines Corp | Becker Hewes | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 104.83 per share. | 31 May 2024 | 6,342 | 36,860 (0%) | 0% | 104.8 | 664,832 | Common Stock |
| Blueprint Medicines Corp | Becker Hewes | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 5,729 | 19,271 | - | - | Stock Options (Right to Buy) | |
| Blueprint Medicines Corp | Becker Hewes | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.15 per share. | 31 May 2024 | 5,729 | 70,968 (0%) | 0% | 43.1 | 247,206 | Common Stock |
| Blueprint Medicines Corp | Becker Hewes | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 107.86 per share. | 31 May 2024 | 3,671 | 67,297 (0%) | 0% | 107.9 | 395,954 | Common Stock |
| Blueprint Medicines Corp | Becker Hewes | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 106.50 per share. | 31 May 2024 | 3,191 | 64,106 (0%) | 0% | 106.5 | 339,842 | Common Stock |
| Blueprint Medicines Corp | Becker Hewes | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 106.43 per share. | 31 May 2024 | 2,971 | 33,889 (0%) | 0% | 106.4 | 316,204 | Common Stock |
| Blueprint Medicines Corp | Becker Hewes | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 106.43 per share. | 31 May 2024 | 1,951 | 31,938 (0%) | 0% | 106.4 | 207,645 | Common Stock |
| Blueprint Medicines Corp | Becker Hewes | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 90.69 per share. | 07 Mar 2024 | 3,097 | 46,281 (0%) | 0% | 90.7 | 280,867 | Common Stock |
| Blueprint Medicines Corp | Becker Hewes | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 25,000 | 25,000 | - | - | Stock Options (Right to Buy) | |
| Blueprint Medicines Corp | Becker Hewes | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 12,500 | 49,378 (0%) | 0% | 0 | Common Stock | |
| Blueprint Medicines Corp | Becker Hewes | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 52.05 per share. | 05 Jun 2023 | 1,404 | 36,878 (0%) | 0% | 52.0 | 73,078 | Common Stock |
| Blueprint Medicines Corp | Becker Hewes | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 45.72 per share. | 06 Mar 2023 | 1,466 | 38,330 (0%) | 0% | 45.7 | 67,026 | Common Stock |
| Blueprint Medicines Corp | Becker Hewes | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 44.77 per share. | 06 Mar 2023 | 48 | 38,282 (0%) | 0% | 44.8 | 2,149 | Common Stock |
| Blueprint Medicines Corp | Becker Hewes | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 25,000 | 25,000 | - | - | Stock Options (Right to Buy) | |
| Blueprint Medicines Corp | Becker Hewes | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 12,500 | 39,796 (0%) | 0% | 0 | Common Stock | |
| Blueprint Medicines Corp | Becker Hewes | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 60.00 per share. | 06 Jun 2022 | 3,155 | 27,296 (0%) | 0% | 60 | 189,300 | Common Stock |
| Blueprint Medicines Corp | Becker Hewes | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 59.76 per share. | 06 Jun 2022 | 1,220 | 30,451 (0%) | 0% | 59.8 | 72,907 | Common Stock |
| Blueprint Medicines Corp | Becker Hewes | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 60.00 per share. | 16 Mar 2022 | 2,219 | 31,671 (0%) | 0% | 60 | 133,140 | Common Stock |
| Blueprint Medicines Corp | Becker Hewes | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 56.19 per share. | 07 Mar 2022 | 1,047 | 33,890 (0%) | 0% | 56.2 | 58,831 | Common Stock |
| Blueprint Medicines Corp | Becker Hewes | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 17,500 | 17,500 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Becker Hewes | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 8,750 | 34,937 (0%) | 0% | 0 | Common Stock | |
| Blueprint Medicines Corp | Becker Hewes | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 115.49 per share. | 15 Nov 2021 | 729 | 26,187 (0%) | 0% | 115.5 | 84,192 | Common Stock |
| Blueprint Medicines Corp | Becker Hewes | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2021 | 729 | 24,792 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Becker Hewes | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 66.24 per share. | 15 Nov 2021 | 729 | 26,916 (0%) | 0% | 66.2 | 48,289 | Common Stock |
| Blueprint Medicines Corp | Becker Hewes | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2021 | 729 | 25,521 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Becker Hewes | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 102.66 per share. | 15 Oct 2021 | 729 | 26,187 (0%) | 0% | 102.7 | 74,839 | Common Stock |
| Blueprint Medicines Corp | Becker Hewes | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 66.24 per share. | 15 Oct 2021 | 729 | 26,916 (0%) | 0% | 66.2 | 48,289 | Common Stock |
| Blueprint Medicines Corp | Becker Hewes | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2021 | 8,750 | 26,250 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Becker Hewes | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 66.24 per share. | 15 Sep 2021 | 8,750 | 38,020 (0%) | 0% | 66.2 | 579,600 | Common Stock |
| Blueprint Medicines Corp | Becker Hewes | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 101.04 per share. | 15 Sep 2021 | 5,759 | 28,121 (0%) | 0% | 101.0 | 581,889 | Common Stock |
| Blueprint Medicines Corp | Becker Hewes | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 101.92 per share. | 15 Sep 2021 | 4,140 | 33,880 (0%) | 0% | 101.9 | 421,949 | Common Stock |
| Blueprint Medicines Corp | Becker Hewes | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 100.05 per share. | 15 Sep 2021 | 1,734 | 26,387 (0%) | 0% | 100.1 | 173,487 | Common Stock |
| Blueprint Medicines Corp | Becker Hewes | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 99.07 per share. | 15 Sep 2021 | 200 | 26,187 (0%) | 0% | 99.1 | 19,814 | Common Stock |
| Blueprint Medicines Corp | Becker Hewes | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 89.03 per share. | 02 Jun 2021 | 1,292 | 29,270 (0%) | 0% | 89.0 | 115,027 | Common Stock |
| Blueprint Medicines Corp | Becker Hewes | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 26,125 | 26,125 | - | - | Stock Option (Right to Buy) | |
| Blueprint Medicines Corp | Becker Hewes | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 13,062 | 30,562 (0%) | 0% | 0 | Common Stock |